Company Description

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics.

Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data.

The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health.

The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021.

Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

Ainos, Inc.

Country	United States
Founded	1984
Industry	Medical Devices
Sector	Healthcare
Employees	44
CEO	Chun-Hsien Tsai

Contact Details

Address: 8880 Rio San Diego Drive, Suite 800 San Diego, California 92108 United States
Phone	858 869 2986
Website	ainos.com

Stock Details

Ticker Symbol	AIMD
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001014763
CUSIP Number	00902F105
ISIN Number	US00902F3038
Employer ID	75-1974352
SIC Code	2834

Key Executives

Name	Position
Chun-Hsien Tsai	Chief Executive Officer, President and Chairman of the Board
Hsin-Liang Lee	Chief Financial Officer
Chih-Heng Lu	Director of Corporate Developoment

Latest SEC Filings

Date	Type	Title
Jun 24, 2025	8-K	Current Report
May 29, 2025	DEF 14C	Filing
May 19, 2025	PRE 14C	Filing
May 14, 2025	10-Q	Quarterly Report
May 12, 2025	8-K	Current Report
Apr 11, 2025	SCHEDULE 13D	Filing
Apr 11, 2025	SCHEDULE 13D	Filing
Apr 9, 2025	SCHEDULE 13D/A	Filing
Apr 4, 2025	S-8	Securities to be offered to employees in employee benefit plans
Mar 14, 2025	8-K	Current Report

View All SEC Filings